Delphi Consensus: First-Line Use of Biologics and Small Molecules in Hidradenitis Suppurativa - EADV | Cliniscan
Cliniscan
Solutions
Tarifs
Ressources
Se connecter
Essayer gratuitement
Cliniscan
Retour aux recommandations
EADV
2026
Delphi Consensus: First-Line Use of Biologics and Small Molecules in Hidradenitis Suppurativa
Document
Analyser ce document